A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis

NCT07083193 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: AC-101

Sponsor

Accro Bioscience (Suzhou) Limited